Help your patients contribute to the future of HIV research 

Who Might Be a Good Fit?

Patients with HIV who:

• Are 18–55 years old
• Are on first-line, oral INSTI-based ART who have well controlled HIV, which is defined as:
  • HIV-1 RNA <50 c/mL at the time of screening (and for the previous 24 months)
  • One HIV-1 RNA blip (defined as an HIV-1 RNA ≥50 but <200 c/mL, that was immediately preceded and followed by HIV-1 RNA <50 c/mL) is allowable in the previous 24 months.
  • CD4+ T-cells >500 cells/mm3 at the time of screening.
• Meet body weight and BMI ranges:
  • Men: ≥110 lbs. (50.0 kg)
  • Women: ≥99 lbs. (45.0 kg)
  • BMI: 18.5–31.0 kg/m²

Key Exclusions:

• Previous use of HIV PrEP or PEP
• Receipt of an investigational HIV vaccine

Why Refer:

This study offers a way for your patients to stay engaged in their care while helping to advance scientific understanding of HIV. Participants will receive regular monitoring and support from our clinical team throughout the study. Participants may also receive compensation proportional to time and travel commitments required for the study.

If you have a patient who may qualify, or if you’d like more details, we’d be happy to connect.

Referrals and questions welcome.

Please contact us to learn more or to refer a potentially eligible patient

By providing your contact information you consent to Trialmed contacting you to discuss potential collaboration opportunities related to clinical research, including identifying potential participants, patient recruitment strategies, and expert consultation. Your decision to provide this consent is voluntary, and you are not obligated to engage in any collaboration.